-
News
NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity
Shelton, Connecticut — (October 11, 2021) – NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a leader in the development of highly…
Read More » -
News
ReelTime’s Technology License Revenues Increase with Rapidly Expanding Virtual Restaurant Munchie Magic
[ad_1] Seattle, WA – (NewMediaWire) – October 7, 2021 – ReelTime VR/ReelTime Media (OTC PK:RLTR) announced that its revenues from…
Read More » -
Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis
[ad_1] Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis…
Read More » -
3DX Launches East Coast Offices at University of Bridgeport Innovation Center
[ad_1] Seattle, WA – (NewMediaWire) – October 7, 2021 – 3DX Industries Inc. (DDDX) (the “Company” or “3DX”), a state of…
Read More » -
Tauriga Sciences Inc. Commences Development of Kratom Extract Infused Chewing Gum
[ad_1] NEW YORK, NY, – (NewMediaWire) – October 7, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a…
Read More »
Trending Tickers
WISH
$9.18
27.72%
WISH
$9.18
27.72%
WISH
$9.18
27.72%
Follow us on Twitter